NCT04337840Unknown不适用
Analysis on the Infection Risk, Prognosis, and Drug Sensitivity of Klebsiella Pneumoniae.
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- All-cause 28-day mortality
研究概览
简要总结
Nosocomial infections are increasing rapidly both internationally and domestically, especially carbapenem-resistant Klebsiella pneumoniae infections. However, there were still lack of evidence about the risk and prognosis in Taiwan. The choice of drug and related sensitivity test was also limited. We would analyze the infection risk, prognosis, and drug sensitivity of Klebsiella pneumoniae and focus on strategy to manage carbapenem-resistant Klebsiella pneumoniae infections.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 21 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
All-cause 28-day mortality
时间窗: 2017-2019
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Therapeutic Monitoring of Antibiotics in Intensive Care Patients: a Cohort Study PopTDM-ICUIntensive Care UnitAntibiotic TherapyPharmacokineticNCT05367011Poitiers University Hospital2,500
已完成
2 期
Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)Infections, Gram-Positive BacterialAbscessBurnsUlcerWound InfectionsCellulitisNCT00061633Cumberland Pharmaceuticals169
已完成
2 期
Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)Infections, Gram-positive BacterialNCT00077675Cumberland Pharmaceuticals201
已完成
不适用
Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19COVID 19Disease OutbreakMental DisordersNCT04417374University Hospital, Montpellier94
已完成
不适用
COG-UK Project Hospital-Onset COVID-19 Infections StudyCovid-19Nosocomial InfectionCoronavirusSARS-CoV 2Coronavirus InfectionNCT04405934University College, London2,170